Table 1 Recipients' characteristics

Age at LTX, median (IQR)

45 (34–51)

50 (44.5–53.5)

43 (33–50)

0.062

Male, n (%)

48 (38.7%)

7 (53.8%)

41 (36.9%)

0.247

LTX procedure, n (%)

 < 0.0001

 Cadaveric single

67 (54.0%)

0 (0.0%)

67 (60.4%)

 Cadaveric bilateral

48 (38.7%)

12 (92.3%)

36 (32.4%)

 Living-donor

9 (7.3%)

1 (7.7%)

8 (7.2%)

LTX indication category, n (%)

N/A

 Suppurative lung disease

13 (10.5%)

13 (100%)

 Restrictive lung disease

30 (24.2%)

30 (27.0%)

 Pulmonary vascular disease

27 (21.8%)

27 (24.3%)

 Obstructive lung disease

51 (39.5%)

51 (49.9%)

 Others

3 (2.4%)

3 (2.7%)

Chronic sinusitis, n (%)

19 (15.3%)

10 (76.9%)

9 (8.1%)

 < 0.0001

Connective tissue disease, n (%)

14 (11.3%)

2 (15.4%)

12 (10.8%)

0.641

Gastroesophageal reflux disease, n (%)

10 (8.1%)

2 (15.4%)

8 (7.2%)

0.282

Diabetes

8 (6.5%)

0 (0.0%)

8 (7.2%)

0.999

Underweight (BMI < 18.5 kg/m2), n (%)

67 (54.0%)

6 (46.2%)

61 (55.0%)

0.571

History of Pseudomonas colonization, n (%)

13 (10.5%)

12 (92.3%)

1 (0.9%)

 < 0.0001

History of NTM isolation, n (%)

5 (4.0%)

1 (7.7%)

4 (3.6%)

0.431

Ischemic time (min), median (IQR)

502 (431–666)

685 (635–734)

493 (429–643)

0.002

CMV mismatch, n (%)

21 (16.9%)

1 (8.3%)

20 (18%)

0.689